PDA Statement Regarding COVID-19
Last updated: April 21, 2020
PDA considers safety and health of event attendees as a subject of utmost importance. This is relevant as attendees from various countries, regions, and continents will come to PDA events. The coronavirus outbreak is a global concern. Our sympathies are with those affected around the world.
PDA is committed to maintaining opportunities for volunteers and individuals from the pharmaceutical industry to meet, wherever we can do so. PDA relies on experts in that field, from global bodies like the World Health Organisation, to national and local health authorities where we are running events, to provide appropriate guidance.
PDA has implemented a set of measures to protect participants and staff from potential risks related to COVID-19 as best as possible. This includes a close and regular monitoring of the situation, adherence to recommendations of health authorities and official travel warnings, possibilities of remote presentations, and precautions being implemented at our venues.
For PDA staff, we are suspending all business travel, until further notice. Our Pandemic Preparedness Plan is in effect, and began teleworking for all US and EU employees on March 16, 2020. We will continue to monitor the situation and make other announcements, as necessary.
We have suspended the expiration of existing memberships until the end of June, 2020. As of now, all members will continue to enjoy the benefits of membership even if you are unable to pay due to the impact of the corona virus pandemic.
Be assured that we will continue to operate and provide the service that our members have come to expect from PDA.